Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

COVID-19 infection during pregnancy increases risk of developing pre-eclampsia, study finds

A newly published study found that women who contract COVID-19 during pregnancy are at significantly higher risk of developing pre-eclampsia, the leading cause of maternal and infant death worldwide.

22 Sep 2021

U.S. vaccination effort against COVID-19 needs intensifying, warn researchers

Researchers have warned that the United States has not yet reached the necessary thresholds for achieving population immunity against severe acute respiratory coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

22 Sep 2021

Researchers encourage longer dosing intervals for Pfizer-BioNTech’s COVID-19 vaccine

Researchers in Canada, Italy, and the United States have encouraged extending the interval time between two doses of Pfizer-BioNTech’s coronavirus disease 2019 (COVID-19) vaccine among individuals who have not previously been infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

22 Sep 2021

Ryans make $25 million gift to name and endow the Robert J. Havey, MD, Institute for Global Health

Northwestern University Trustees and alumni Patrick G. Ryan and Shirley W. Ryan have made a $25 million gift to name and endow the Robert J. Havey, MD, Institute for Global Health at Northwestern University Feinberg School of Medicine.

22 Sep 2021

Pregnant women who receive COVID-19 vaccine pass high levels of antibodies to their babies

Women who receive the mRNA COVID-19 vaccine during pregnancy pass high levels of antibodies to their babies, a new study finds.

22 Sep 2021

mRNA-based and adenoviral vector-based COVID-19 vaccines elicit diverse humoral immunity

Scientists from the USA have recently compared the dynamics of humoral and cellular immune responses induced by mRNA-based and adenoviral vector-based coronavirus disease 2019 (COVID-19) vaccines. The findings reveal a difference in humoral immune responses. The study is currently available on the medRxiv* preprint server.

22 Sep 2021

The importance of handwashing in the COVID-19 era: Back to basics

Researchers from the United States have reviewed the different components of formulated soaps and their performance as cleansers and pathogen inactivators, the criticality of the time spent hand washing, the relationships between water temperature and pathogen inactivation.

22 Sep 2021

Pinning down Pin1: Potential COVID-19 therapy

In a recent study scientists have demonstrated that Pin1 is one of the key cellular molecules necessary for SARS-CoV-2 propagation.

22 Sep 2021

The role of nanomaterials during the COVID-19 pandemic

A new review published in Rare Metals has focused on the applications of nanomaterials to fight the ongoing COVID-19 pandemic.

22 Sep 2021

Will ‘Dr. Disinformation’ ever face the music?

Earlier this month, Dr. Rashid Buttar posted on Twitter that covid-19 "was a planned operation" and shared an article alleging that most people who got the covid vaccine would be dead by 2025.

22 Sep 2021

Hypertonic saline solution shown to inhibit replication of SARS-CoV-2

Researchers at the University of São Paulo (USP) in Brazil have shown that a hypertonic saline solution inhibits replication of SARS-CoV-2, the virus that causes COVID-19, and have elucidated the biochemical mechanism involved.

22 Sep 2021

COVID-19 vaccination in IBD patients

In this review, researchers reviewed all published research related to Phase 1/2 and/or Phase 3 and 4 studies of SARS-CoV-2 vaccinations.

22 Sep 2021

Unique tiny Ilamas antibodies could be used for treatment of COVID-19

A unique type of tiny antibody produced by llamas could provide a new frontline treatment against Covid-19 that can be taken by patients as a simple nasal spray.

22 Sep 2021

SARS-CoV-2 genome signature leads to replicative advantage in presence of Remdesivir

A new study indicates that low-level resistance of SARS-CoV-2 to remdesivir is not widespread and dissimilar to other RNA viruses revealing evolutionary predictability of this pandemic virus.

22 Sep 2021

Public health experts ‘flabbergasted’ that Biden still hasn’t picked an FDA chief

President Joe Biden's failure to name someone to lead the Food and Drug Administration, more than 10 months after the election, has flummoxed public health experts who say it's baffling for the agency to be without a permanent leader during a national health crisis.

22 Sep 2021

At an overrun ICU, ‘the problem is we are running out of hallways’

Nurses fill the hospital room to turn a patient from his stomach to his back. The ventilator forcing air into him is most effective when he's on his stomach, so he is in that position most hours of the day, sedated and paralyzed by drugs.

22 Sep 2021

Evidence for safety of Pfizer-BioNTech’s COVID-19 vaccine booster dose

Researchers have conducted a study demonstrating the safety of administering a third (booster) dose of Pfizer-BioNTech’s BNT162b2 vaccine.

22 Sep 2021

SARS-CoV-2 delta variant has higher viral RNA levels and increased infectivity, suggests study

The study found that the delta and epsilon variants exhibited significantly higher infectivity than alpha, with delta containing approximately six times as much infectious virus for the same amount of RNA.

22 Sep 2021

Experts discover new approach to motivate people for vaccinations and masking

In the face of a global pandemic, with more than 200 million global infections and 4 million deaths, and despite unprecedented efforts by public health officials, celebrities and influencers to convince everyone to wear masks and get vaccinated as soon possible, the results are mixed.

22 Sep 2021

New framework needed to explore links between evolved pathogen tolerance and emerging infections

A new multidisciplinary research framework is needed to explore links between evolved tolerance to pathogens and their spillover into humans, scientists write today in the journal eLife.

22 Sep 2021

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

COVID-19 infection during pregnancy increases risk of developing pre-eclampsia, study finds

U.S. vaccination effort against COVID-19 needs intensifying, warn researchers

Researchers encourage longer dosing intervals for Pfizer-BioNTech’s COVID-19 vaccine

Ryans make $25 million gift to name and endow the Robert J. Havey, MD, Institute for Global Health

Pregnant women who receive COVID-19 vaccine pass high levels of antibodies to their babies

mRNA-based and adenoviral vector-based COVID-19 vaccines elicit diverse humoral immunity

The importance of handwashing in the COVID-19 era: Back to basics

Pinning down Pin1: Potential COVID-19 therapy

The role of nanomaterials during the COVID-19 pandemic

Will ‘Dr. Disinformation’ ever face the music?

Hypertonic saline solution shown to inhibit replication of SARS-CoV-2

COVID-19 vaccination in IBD patients

Unique tiny Ilamas antibodies could be used for treatment of COVID-19

SARS-CoV-2 genome signature leads to replicative advantage in presence of Remdesivir

Public health experts ‘flabbergasted’ that Biden still hasn’t picked an FDA chief

At an overrun ICU, ‘the problem is we are running out of hallways’

Evidence for safety of Pfizer-BioNTech’s COVID-19 vaccine booster dose

SARS-CoV-2 delta variant has higher viral RNA levels and increased infectivity, suggests study

Experts discover new approach to motivate people for vaccinations and masking

New framework needed to explore links between evolved pathogen tolerance and emerging infections

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in